Evaluation of diagnostic criteria for IgG4-related tubulointerstitial nephritis by unknown
Tang et al. Diagnostic Pathology  (2015) 10:83 
DOI 10.1186/s13000-015-0311-3RESEARCH Open AccessEvaluation of diagnostic criteria for IgG4-
related tubulointerstitial nephritis
Xuanli Tang1†, Bin Zhu1, Riping Chen2, Yunqin Hu1, Yinghua Zhang1, Xiaoling Zhu1, Hongyu Chen1*†
and Yongjun Wang1Abstract
Background: IgG4-TIN is the most common pattern of renal involvement in IgG4-related disease. There are several
proposed diagnostic criteria of IgG4-TIN recently. Two of them proposed by the Mayo Clinic and JSN are
predominant. However, histopathological criteria of the number of IgG4+ plasma cells and several histological
features are still under discussion due to low amount of tissue in renal biopsy specimens and low frequency of this
kind of specimens. We aimed to screen IgG4-TIN on archived renal biopsy samples and evaluated the application of
two proposed diagnostic criteria.
Methods: We selected 480 interstitial inflammation samples for light and electron microscopy and immunohistochemistry
of CD138, IgG and IgG4 test. The Mayo Clinic proposed criteria diagnosed high-probability IgG4-TIN and JSN
criteria confirmed IgG4-TIN.
Results: Twelve high-probability IgG4-TIN were screened by histology, imaging, serology and other organ
involvement according to the Mayo Clinic proposed criteria. The previous principal pathological diagnoses were
IgAN (n=4), CreGN (n=4), tubulointerstitial nephritis (n=3) and LN (n=1). Three cases showed storiform fibrosis and
a bird’s eye pattern. The distribution of IgG4+ plasma cells was focal, multifocal or diffuse, with a mixed mild,
moderate or strong stainingpattern. Their treatment and clinical outcomes varied depending on different levels of
proteinuria, serum creatinine, eGFR and original glomerular disease presentation. Therefore, we applied strict
histological criteria of storiform fibrosis and evenly distributed IgG4+ plasma cells by JSN to confirm typical
IgG4-TIN. Two cases were finally diagnosed as real IgG4-TIN. One was previously diagnosed as idiopathic interstitial
nephritis with rapid response to corticosteroid therapy. The other was CreGN with immune complex deposits,
which had poor outcome and long-term hemodialysis.
Conclusions: IgG4-TIN might present concurrently with glomerular disease. The proposed criteria by the Mayo
Clinic is flexible, sensitive, and superior in the identification of early-stage or atypical IgG4-TIN, with enhanced risk
of misdiagnosis as compared to the proposed criteria by JSN, which is stricter, more specific, and might overlook
early-stage or atypical IgG4-TIN. We propose a new set of criteria to improve pathologist-derived diagnosis.
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IgG4-RD is recognized as a systemic autoimmune dis-
ease that is characterized by significant lymphoplasma-
cytic infiltration of IgG4 positive plasma cells, with
obliterative phlebitis and storiform fibrosis leading to
organ swelling or nodular lesions [1–3]. It was first rec-
ognized as sclerosing or AIP, which usually occurs with
multi-organ involvement. Single organ injury such as
kidney damage was reported occasionally [2–6]. IgG4-
TIN was the most common pattern of renal involvement
[7–11]. There were several proposed diagnostic criteria
of IgG4-TIN in recent years, most of which emphasized
histological features and rich IgG4+ plasma cells as in-
dispensable criteria [3, 11, 12]. Nevertheless, the suitable
cut-off values of IgG4+ plasma cells and the diagnostic
strength of other specific histopathologic features are
still debated in literature, also due to low amount of tis-
sue in renal biopsy specimens and low frequency of this
kind of specimens. In addition, IgG4 analysis in renal
biopsy was not routinely performed previously, thus
IgG4-TIN awareness was suffered and it would be easily
misdiagnosed, especially when the morphological appear-
ance was atypical. In this study, we retrospectively
screened IgG4-TIN from archived renal biopsy samples,
analyzed their clinical pathological characteristics and
evaluated the utility of two proposed diagnostic criteria to
identify their potential advantages and disadvantages.
Materials and Methods
Patients’ selection
Patients with sufficient acute or chronic interstitial in-
flammation (the frequency of inflammatory cells that
were > 25 % within the cortical interstitium) by light
microscopy were enrolled in this study from April 2008
through December 2013, irrespective of the presence or
absence of glomerular disease. Altogether, 480 patients
who were first admitted as renal injury without anyTable 1 Two proposed criteria for IgG4-TIN by the Mayo Clinic and
Criterion The Mayo Clinic criteria
Histology Plasma cell-rich TIN with >10 IgG4+ plasma cells
the most concentrated field (mandatory criterion
TBM immune complex deposits by immunofluo
immunohistochemistry, and/or electron microsc
Imaging Small peripheral low-attenuation cortical nodule
wedge-shapped lesions, or diffuse patchy involv
Serology Elevated serum IgG4 or total IgG level
Clinical features None
Other organ involvement Characteristic findings of IgG4-RD in other organ
Definite IgG4-TIN The histologic feature and at least one other fea
imaging, serology or other organ involvementremarkable medical history were studied following ap-
proval by the ethical committees of Hangzhou Hospital
of Traditional Chinese Medicine.
HE-stained slides were reviewed by two pathologists.
Cases were selected by lightmicroscopy as having an
average plasma cell count of more than 5 plasma cells in
at least 3 HPF fields [12]. Sections from the corresponding
paraffin-embedded tissue blocks were recut and immuno-
stained for the following antibodies: CD138 (#IR642; 1:50;
Dako Cytomation, Glostrup, Denmark), IgG (#A0423;
1:250; Dako Cytomation, Glostrup, Denmark) and IgG4
(#AU009; 1:500; Binding Site, Birmingham, UK). Antigen
was retrieved by EDTA solution as well as gastric enzyme,
and Elivision system was applied in IHC detection. The
positive cell counting was calculated as an average number
per HPF over three fields. Abundant plasma cells were de-
fined as more than 20/HPF. Suspected IgG4-TIN were de-
fined as IgG4 positive cells > 10/HPF or IgG4/IgG positive
cells >40 %.
Screening for high-probability IgG4-TIN
High-probability IgG4-TIN cases were screened according
to the criteria proposed by the Mayo Clinic as shown in
Table 1 [12]. Clinical and laboratory features including age,
gender, microscopic hematuria (−, <3; ±, 3–10; + 11–20; 2
+, 21–40; 3+, 41–100; 4+, >100), 24-hour proteinuria, albu-
min, SCr, eGFR and IgG levels were then analyzed. The
presence of eGFR was calculated by the mordification of
diet in renal disease (MDRD). Histological features, deter-
mined on the basis of previous pathological studies of
IgG4-RD were reanalyzed [3, 9, 13–17]. Immune complex
deposits in TBM were observed by IgG test and electron
microscopy.
Confirmation of IgG4-TIN
The histological criterion proposed by JSN was much




a. Dense lymphoplasmacytic infiltrate with >10 IgG4+




b. Characteristic storiform fibrosis
s, round or
ement
Multiple low-density lesions on enhanced CT,
diffuse kidney enlargement, hypovascular solitary
nodule, hypertrophic lesion of the renal pelvic wall
Elevated serum IgG4 or total IgG level
Clinical or laboratory evidence of kidney damage
s Characteristic findings of IgG4-RD in other organs
ture from The histologic feature (a and b) and at least two of
other features from imaging, serology or other organ
involvement
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IgG4 positive cells should be marked and densely stained
[18, 19]. We followed this guideline to confirm IgG4-
TIN since lesions were numerous in our study, including
many different glomerular diseases that might lead to a
misdiagnosis of the underlying condition. Therefore con-
firmed IgG4-TIN was screened from a high-probability
IgG4-TIN group according to the criteria proposed by
JSN.Statistical analysis
Statistical analysis was performed with SPSS software ver-
sion 17.0. Normally distributed data were expressed as
mean ± SD. The clinical characteristics between two groups
were compared by Student’s t test. Categorical variables of
histological features between two groups were expressed as
percentages and were compared by Chi-square test or Fish-
er’s exact test. Correlations were assessed by Spearman’s
rank correlation to estimate the relationship of the clinical
characteristics associated with IgG4 positive cells and the
stage of interstitial fibrosis. P-values less than 0.05 were
considered statistically significant.Results
Cases of suspected IgG4-TIN
The procedure of screening cases is shown in Fig. 1.
Herein, 480 samples with sufficient interstitial inflamma-
tion that accounted for 24.2 % of total renal biopsy speci-
mens were selected in our study. After re-observing these
specimens by light microscopy, 55 cases demonstrating
abundant plasma cells were screened. Furthermore, 21Fig. 1 The procedure of screening casescases of suspected IgG4-TIN were screened from the pre-
vious group by CD138, IgG and IgG4 test, which
accounted for 38.2 % of abundant plasma cell cases and
4.4 % of sufficient inflammation cases. The average
number of CD138, IgG and IgG4 positive cells were
75.8 ± 34.9, 34.0 ± 21.3 and 19.9 ± 13.3 respectively.
Their predominant pathological diagnoses were IgAN,
CreGN and TIN respectively, whilst others were FSGS,
LN, MN and SS.
Cases of high-probability IgG4-TIN
According to the proposed criteria of the Mayo Clinic
[12], twelve cases were screened at least for one other fea-
ture from the imaging, serology, or other organ involve-
ment, which accounted for 57.1 % of suspected cases of
IgG4-TIN. The average age was 52 years (range, 30 to
76 years). Six cases were male and the other six were
female. Patients were much older (p < 0.01) whereas the
incidence of proteinuria was lower (p < 0.05) than that
of excluded cases (please see Table 2). In addition,
Table 3 showed clinical and pathological features of
twelve cases. Ten cases (or 83.3 %) had increased
serum IgG levels; three cases (or 25 %) showed diffuse
enlargement of both kidneys, six cases (or 50 %) pre-
sented with pulmonary interstitial fibrosis and one case
had lymph node enlargement. All but one of the cases
manifested acute (n = 6) or chronic (n = 5) renal failure.
Originally, nine cases were diagnosed with glomerular
diseases and three cases were diagnosed with TIN patho-
logically. Both CreGN and IgAN were predominant
glomerular diseases among them. The others were idio-
pathic TIN, drug-induced TIN and LN (Table 3). Most
of their histological features were non-specific; however,
storiform fibrosis and a bird’s eye pattern were signifi-
cantly more frequent than that in the excluded cases
(p < 0.01; Table 4). Moreover, IgG4+ plasma cells were
focal, multi-focal or evenly distributed, with mild, moder-
ate or strongly stained mixed expression patterns (Fig. 2).
Fibrosis was mild or moderate with multifocal distribution.Table 2 The comparison of clinical characteristics between
the high-probability IgG4-TIN group and excluded group in
abundant plasma cells samples
High-probability




Female gender (n (%)) 6 (50 ) 26 (60 ) 0.152
Age (y) 52 (30–76) 37 (14–63) 0.003
Proteinuria
(0.01-0.15 g/24 h)
1.04 (0.21 - 2.69) 3.12 (0.06 - 17.33) 0.043
Albumin (35–55 g/L) 32.8 (25.7 - 42.1) 31.8 (15–46) 0.682
Serum creatinine
(44–132 μmol/L)
311.7 (46–953) 492.8 (105–1832) 0.070
eGFR (80-120 ml/min) 23.6 (5.4 - 65.3) 29.5 (3.2 - 143.1) 0.405
Data are expressed as mean (minimum, maximum), number (frequency)








































1 65 M ARF 0.30 - 36 381 13.2 1910 67 Idiopathic
TIN
14 23.3 - 0 - Bilateral
Enlarged
-
2 42 F ARF,
AAV
1.41 4+ 35 447 9.9 2370 78 Pauci-
immune
CreGN
22 56.7 - 0 + - -
3 52 F SLE,
CRF
1.57 2+ 30 273 15.5 3050 86 LN 11 84.6 - 1 + - PF
4 76 M CGN,
CRF
1.41 4+ 33 380 11.9 1990 75 Immune
complex
CreGN
10 43.5 - 1 - - PF
5 62 M CGN,
CRF
1.17 - 30 234 25.6 4050 45 Idiopathic
TIN





6 49 M CGN,
CRF
0.40 3+ 37.6 138 52 1050 81 IgAN 12 32.2 - 1 + - PF
7 33 F ARF 0.21 - 39.9 231 24.9 2010 123 Drug-
induced
TIN
22 58 - 1 + - -
8 59 M ARF 0.60 3+ 26.6 1108 10.7 1380 86 Anti-GBM
CreGN
29 60.3 - 1 - - PF
9 36 F CGN,
CRF
2.69 3+ 30.4 199 40.7 1910 121 IgAN 14 40.3 - 2 + - -
10 56 F ARF,
AAV
1.58 3+ 26.9 1832 5.4 2120 80 Crescentic
IgAN
20 95 + 1 + - PF
11 59 M ARF 0.49 - 25.7 586 8.4 1860 106 Immune
complex
CreGN
52 91 + 2 + Bilateral
Enlarged
-
12 30 F CGN,
CKD2
0.61 - 42.1 105 65.3 1870 109 IgAN 25 63.7 - 2 + - -











Table 4 Pathological features of confirmed IgG4-TIN, high-probability IgG4-TIN and both excluded groups in abundant plasma cells
samples
Abundant plasma cells samples High-probability IgG4-TIN
Pathological features High-probability
IgG4-TIN (n = 12)
Excluded
(n = 43)
P value 1 Confirmed




Inflammation infiltrating renal capsule 4 (33.3 ) 11 (25.6) 0.594 1 (50) 3 (30) 0.584
Inflammation infiltrating renal medulla 6 (50) 23 (53.5) 0.831 1 (50) 5 (50) 1.000
Isolated fibrosis 6 (50) 3 (7) 0.000 2 (100) 4 (40) 0.121
Collagenous fibrosis 8 (66.7) 7 (16.3) 0.001 2 (100) 6 (60) 0.273
Storiform fibrosis 3 (25) 1 (2.3) 0.007 2 (100) 1 (10) 0.007
Lymphoid follicles 2 (16.7) 1 (2.3) 0.053 0 (0) 2 (20) 0.488
Granulomatous lesions 1 (8.3) 0 (0) 0.056 0 (0) 1 (10) 0.640
Necrotizing angiitis 1 (8.3) 1 (2.3) 0.326 0 (0) 1 (10) 0.640
Obliterative phlebitis 0 (0) 0 (0) – 0 (0) 0 (0) –
Eosinophil infiltration 8 (66.7) 18 (41.9) 0.128 2 (100) 6 (60) 0.273
Neutrophil infiltration 6 (50) 14 (32.6) 0.267 1 (50) 5 (50) 1.000
Tubulitis 9 (75) 16 (37.2) 0.020 2 (100) 7 (70) 0.371
Peritubular capillaritis 3 (25) 13 (30.2) 0.724 1 (50) 2 (20) 0.371
Tubular necrosis 8 (66.7) 18 (41.9) 0.128 0 (0) 8 (80) 0.091
TBM immune complex deposits 9 (75) 12 (27.9) 0.006 2 (100) 7 (70) 0.371
Data are expressed as number (frequency); P value 1: High-probability IgG4-TIN compared to Excluded; P value 2: Confirmed IgG4-TIN compared to
unconfirmed; –: no statistics.
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most cases were in stage 1. It was neither significantly
correlated with the number of IgG4+ cells (r = 0.433,
P = 0.160) nor TBM immune complex deposits (r = 0.426,
P = 0.167). Both the number of IgG4 positive cells and the
stage of interstitial fibrosis had no significant correlation
with clinical laboratorial characteristics (age, hematuria,
proteinuria, albumin, SCr and eGFR) (P > 0.05). Tubulitis
presented with significant differences between both
groups, though it was not included into specific features
of IgG4-TIN (p < 0.05; Table 4). Moreover, IgG or electron
dense deposits in TBM were more frequently observed in
the high-probability cases than excluded cases (p < 0.05;
Table 4).
Cases of confirmed IgG4-TIN
In the high-probability IgG4-TIN group, all 12 cases pre-
sented with substantial histological differences, including
the stage of fibrosis, the number of IgG4 positive cells
and their distribution. Their treatment and clinical out-
comes were absolutely different, and were dependent, at
least in part, on proteinuria, serum creatinine, eGFR and
presence of original glomerular disease. Therefore, we
applied strict morphological criterion by JSN to confirm
the diagnosis of IgG4-TIN and found three cases that
met it. Two cases (case 5 and case 11) met all criteria of
histology, imaging, serology and other organ involve-
ment. The left case (case 10) met all criteria but the im-
aging criterion.. The histological feature of this case,such as storiform fibrosis, was mild and distributed fo-
cally. Moreover, IgG4 positive cells were unevenly dis-
tributed and moderately stained. Therefore, we checked
through the finding of more references, in which it was
recommended to identify the presence of dense, diffuse
infiltrates of IgG4 positive cells >50/HPF, which were
highly specific [20–24]. Moreover, an immunohisto-
chemical study of IgG4-TIN from JSN showed the aver-
age number of IgG4 positive cells was 43.8/HPF [5].
Besides, Houghton DC and Troxell ML presented that
the distribution of IgG4 positive cells were even and uni-
form in IgG4-TIN, while they were focal or multi-focal
in various settings of interstitial nephritis [17]. Finally,
we put the remained one case in the high-probability
IgG4-TIN group, from which two cases were finally con-
firmed as IgG4-TIN. One of IgG4-TIN manifested ARF
and the principal pathological diagnosis was immune com-
plex CreGN. His serum ANCA was negative, which had
no proof of AAV. The serum IgG4 level had decreased rap-
idly after a large dose of corticosteroid treatment, whereas
his serum creatinine hardly decreased and hemodialysis
was finally applied. Another case displayed chronic renal
failure and the previous diagnosis was idiopathic TIN.
Serum IgG4 level was undetectable at this time. Large dose
of corticosteroids was prescribed and serum creatinine had
decreased to normal level by one half month later. Both
cases presented with a diffuse bird’s-eye pattern and focal
storiform features [25] (Fig. 3), whereas there was only one
case that showed specific fibrosis in ten left cases, which
Fig. 2 Histological features and immunohistochemistry findings of case twelve. a) Multi-focal fibrosis with obliteration of several tubules (×40) HE.
b) Isolated glomeruli in the middle of fibrosis (×100) PAM. c) IgA deposits in mesengium (×200) IF. d) Multi-focally distributed plasma cells by
CD138 test (×100) IHC. e) Focally scattered IgG4 positive cells by IgG4 test (×100) IHC. f) IgG4 test (×200) IHC
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IgG4+ plasma cells were presented at a frequency of more
than 50 per HPF, which appeared as an evenly strong stain-
ing pattern with diffuse infiltration of the renal intersti-
tium, while it was multifocal in left cases. No tubular
necrosis was observed in confirmed cases, though it was
frequently shown in the left cases.Discussion
The epidemiology and etiology of IgG4-TIN remain un-
clear. It has been hypothesized that autoimmune disor-
ders and allergic reactions might be the heterogeneous
causes [26–28]. However, this was opposed by several
researchers. They demonstrated that IgG4 antibody
inhibited activation of complement to suppress immune
reactivity. Moreover, a specific allergen was never de-
tected [29, 30]. Recently, it was reported that IgG4-TIN
was associated with a hematological disorder [31]. Thus,
the pathogenesis of this disease remains unclear.The characteristic histological features such as stori-
form fibrosis and a bird’s-eye pattern were shown in
more than 90 % of IgG4-TIN cases by JSN [18, 32]. By
contrast, these presentations were shown in only 17.1 %
of cases in the Mayo Clinic [12]. Therefore, several stud-
ies tried to define the stages of fibrosis to achieve con-
sensus [19]. In our study, most of the high-probability
IgG4-TIN cases showed that mild or moderate fibrosis
and the typical storiform pattern was rarely observed.
However, a bird’s-eye pattern was easier to find with nu-
merous plasma cell nests encircled in fibrosis [25]. We
presumed that this was an early characteristic feature of
IgG4-TIN, which would progress to storiform fibrosis.
In addition, immune complex deposition in TBM was
reported to be more easily observed than specific fibrosis
[12, 19]. In the present study, immune complex depos-
ition was marginally more frequently observed than spe-
cific fibrosis in the high-probability IgG4-TIN group,
although they all presented in the confirmed group.
Some common features, such as extension of lesions
Fig. 3 Pathological features of case five of histology, IHC and electron microscopy. a) Diffuse fibrosis with obliteration of most tubules and isolation of
glomeruli (×40) HE. b) Typical storiform fibrosis with abundant inflammation cells (×200) PAM. c) Rich collagen fibrosis and characteristic bird’s-eye
pattern (×200) Masson trichrome staining. d) Characteristic bird’s-eye pattern (×400) PAM. e) Abundant, evenly distributed, strong positive plasma cells
in interstitium by CD138 test (×100) IHC. f) Abundant strong stained and evenly distributed IgG4+ plasma cells (>50 per HPF) in interstitium and
tubular epithelial cells by IgG4 test (×200) IHC. g) Apparent TBM deposition of two tubules by IgG test (×200) IHC. h) Thickened TBM with scattered
electron dense immune complex deposits (×4000) EM
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indicated IgG4-TIN; while tubulitis, peritubular capillari-
tis, necrotizing angiitis and neutrophil infiltration were
negatively suggestive of IgG4-TIN [19, 25]. However, we
found that only tubulitis was more frequent in high-
probability IgG4-TIN than that in the excluded cases.Eosinophil infiltration was demonstrated to reproducibly
be seen in IgG4-TIN [12, 13, 19], although it was not
significantly different from other TIN cases such as aller-
gic interstitial nephritis or acute CreGN in our study. This
might be explained by that the lesions seen in our cases
were much more variable, including many glomerular
Fig. 4 A new set of criteria of IgG4-TIN for pathologist
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sinophil and neutrophil infiltration were non-specific.
The clinical and pathological evidence of unconfirmed
IgG4-TIN remain understudy. It’s unknown whether
IgG4-TIN is concurrent with or earlier than glomerular
lesions, or the second injury of glomerular diseases. In
previous studies, some pauci-immune CreGN, DN, LN
and MN met the criteria of IgG4 > 10 per HPF, but they
were not real IgG4-TIN [12, 17]. The fibrosis and in-
flammatory lesions of these suspected cases were patchy
or segregated, and IgG4+ plasma cells were focally and
less densely distributed, which was different from the
IgG4-TIN. In our study, cases were selected irrespective
of glomerular disease, thus glomerular nephritis with
interstitial IgG4 positive cells was included in high-
probability IgG4-TIN, but their histological features had
remarkable differences. Moreover, their reaction to treat-
ment and prognosis varied considerably from each other.
Six cases recovered well from poor renal function, two
cases remained stable, and four cases progressed to end
stage renal disease requiring long-term hemodialysis.
Therefore we used the stricter criteria proposed by JSN
and finally confirmed two cases. One had acute glom-
erular nephritis, which convinced us to believe that
IgG4-TIN could co-exist with glomerulonephritis,
wherein the prognosis was much worse and the patient
depended on long-term hemodialysis. Although ten left
high-probability cases met the proposed criteria by the
Mayo Clinic, their clinical manifestations, histological
features, treatment and prognosis varied from each
other. Thus, we currently consider them to be unreal
IgG4-TIN, although frequent follow-up will be necessary
to verify. The proposed criteria by the Mayo Clinic are
much looser and more sensitive, which makes it easier
to determine early-stage or atypical IgG4-TIN, althoughit increases the risk of misdiagnosis. By contrast, the
proposed criteria by JSN are much stricter and more
specific, and yet early-stage or atypical IgG4-TIN might
be easily missed. Therefore, we propose a new set of cri-
teria for renal biopsy patients in Fig. 4, which would en-
able the pathologist to make more accurate diagnosis.
Further, studies of more accumulated cases and long-
term follow-up are necessary for etiology and proposing
criteria of atypical IgG4-TIN.
Conclusion
IgG4-TIN is easily missed without IgG4 test at the time
of renal biopsy. The essential nature of increased IgG4
plasma cells is unclear and it will exist in various kid-
ney diseases meanwhile. Strict histological criteria are
helpful, and sometimes necessary in differentiation of
IgG4-TIN.
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